A young lawyer with expertise in international finance, Andreas Bohrer raised some eyebrows among his colleagues when he transitioned from regional general counsel of the Swiss bank UBS to a position with the Swiss pharmaceutical giant Novartis in 2010. “I was going from private wealth to private health,” is how the now 49-year-old Bohrer sums […]